Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users
- PMID: 12581944
- DOI: 10.1207/s15327558ijbm1001_01
Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users
Abstract
The study, carried out in the French MANIF 2000 cohort of HIV positive patients contaminated through injecting drug use, assessed the impact of patients' sociodemographic and psychological characteristics, behaviors toward drug abuse, and antiretroviral treatment characteristics on the maintenance of adherence to HAART (highly active antiretroviral therapies). A total of 96 patients (30 men and 66 women), who were initially adherent at their first visit after HAART prescription, were considered for analysis. Among these 96 patients, 22 (22.9%) experienced adherence failure defined as a self-reported, non-adherence behavior at any visit before the 18th month of treatment. Logistic regression showed that lack of a stable relationship, active drug injection, and depression were independently associated with adherence failure. Patients' counseling for facilitating maintenance of adherence to HAART over time should focus on prevention of drug use, provision of social support and consider the potential impact of difficulties with treatment on psychological well-being.
Similar articles
-
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.Antivir Ther. 2005;10(1):53-61. Antivir Ther. 2005. PMID: 15751763
-
Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.Antivir Ther. 2004 Jun;9(3):407-14. Antivir Ther. 2004. PMID: 15259903
-
Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.AIDS. 2000 Jan 28;14(2):151-5. doi: 10.1097/00002030-200001280-00010. AIDS. 2000. PMID: 10708285 Clinical Trial.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S123-7. doi: 10.1097/00126334-200212153-00007. J Acquir Immune Defic Syndr. 2002. PMID: 12562034 Review.
Cited by
-
Adherence to antiretroviral therapy: merging the clinical and social course of AIDS.PLoS Med. 2005 Dec;2(12):e338. doi: 10.1371/journal.pmed.0020338. Epub 2005 Oct 4. PLoS Med. 2005. PMID: 16187735 Free PMC article. Review.
-
Selection in context: patterns of natural selection in the glycoprotein 120 region of human immunodeficiency virus 1 within infected individuals.Genetics. 2004 Aug;167(4):1547-61. doi: 10.1534/genetics.103.023945. Genetics. 2004. PMID: 15342497 Free PMC article.
-
"It's Not What You Know but Who You Know": Role of Social Capital in Predicting Risky Injection Drug Use Behavior in a Sample of People who Inject Drugs in Baltimore City.J Subst Use. 2016;21(6):620-626. doi: 10.3109/14659891.2015.1122098. Epub 2016 May 9. J Subst Use. 2016. PMID: 28154497 Free PMC article.
-
Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.AIDS Patient Care STDS. 2010 Jul;24(7):421-8. doi: 10.1089/apc.2009.0240. AIDS Patient Care STDS. 2010. PMID: 20578910 Free PMC article.
-
Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10.Addiction. 2012 Jan;107(1):118-28. doi: 10.1111/j.1360-0443.2011.03609.x. Epub 2011 Oct 12. Addiction. 2012. PMID: 21819473 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical